Mayer Eldon C. III

Track

Insider profile

Performance

Overall performance
0.7
Performance over holding periods
0.7
30 days 90 days 120 days
Average return -17% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mayer Eldon C. III's trades of Eiger BioPharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-21 2023-03-17
S Sale
38,470 -42.6%
328.86
US$3,553,719 		38,470 -42.6% 328.86 US$3,553,719
2023-03-21 2023-03-17
S Sale
64,251 -33.0%
213.17
US$1,175,896 		64,251 -33.0% 213.17 US$1,175,896
2022-03-14 2022-03-14
S Sale
56,165 -45.1%
163.71
US$1,251,676 		56,165 -45.1% 163.71 US$1,251,676
2022-01-11 2022-01-07
S Sale
1,560 -3.3%
4.95
US$7,722 		1,560 -3.3% 4.95 US$7,722
2021-01-11 2021-01-08
S Sale
1,690 -4.5%
11.68
US$19,739 		1,690 -4.5% 11.68 US$19,739
2020-01-30 2020-01-24
B Purchase
5,000 +20.0%
13.52
US$67,602 		5,000 +20.0% 13.52 US$67,602